Ten months after the BIO 2006 International Conference in Chicago, the Illinois Biotech Industry Organization
(IBIO) held its own annual event. After all the excitement and energy coming from 20,000 attendees and visitors coming from 62 countries last April, the IBIO meeting was quiet in comparison.
Although there were more......Full article >>>
: Proximity to these centers has financial benefits as these institutions receive substantial government funding, as well as private-sector funding for both basic and translational research. Additionally, key intellectual property, around which companies are formed, is found here.
Access to talent: This point is linked to the previous one as these world-class research centers (a......Full article >>>
ge patient populations to accelerate proper patient enrollment and recruitment, and help shorten what can be long lead times.
Favorable incentives and tax treatment: It is not only the menu of government (state and municipal) incentives that are potentially available to local bioscience companies here, but the time period it takes to obtain such incentives and the level of compl......Full article >>>
undation, a Washington think-tank that assessed all 50 states and 26 different areas related to innovation.
The top 10 states in this assessment were:
1. Massachusetts, 96.1
2. New Jersey, 86.4
3. Maryland, 85.0
4. Washington, 84.6
5. California, 82.9
6. Connecticut, 81.8
......Full article >>>
a share of total employment.
So what do these two different assessments mean for the Midwest and its life science communities? Well, the reality is we continue to have several growing bioscience clusters in the Midwest, including Chicago/Champaign-Urbana, Minneapolis, St. Louis, Cleveland/Columbus, and Madison/Milwaukee.
The problem is that none of ......Full article >>>
ay attention to the key common ingredients to make it happen.
See you soon!
Previous articles by Michael Rosen
Michael Rosen: The deconstruction of Big Pharma
Michael Rosen: The 10 biggest events shaping biotech in 2006
Full article >>>
Source:wistechnology.com By Michael Rosen 02/26/07Related biology technology :1
. Perscitus Biosciences secures $250K Commerce loan2
. Quintessence Biosciences advances cancer drug3
. Quintessence Biosciences names new president4
. Caden Biosciences may signal critical mass5
. Wisconsin start up Primorigen Biosciences corrals out-of-state investment6
. WARF signs licensing pact with BD Biosciences7
. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces8
. Bioscience beats beer9
. State awards QRG Biosciences development grant10
. EMD Biosciences partners with European biotech company11
. Quintessence Biosciences forms cancer therapeutic advisory board